UBS Maintains Buy on Teradyne, Raises Price Target to $170
Portfolio Pulse from Benzinga Newsdesk
UBS analyst Timothy Arcuri maintains a Buy rating on Teradyne (NASDAQ:TER) and raises the price target from $130 to $170.
June 18, 2024 | 2:31 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
UBS analyst Timothy Arcuri has maintained a Buy rating on Teradyne and increased the price target from $130 to $170, indicating strong confidence in the company's future performance.
The increase in the price target from $130 to $170 by a reputable analyst at UBS suggests a strong positive outlook for Teradyne. This is likely to boost investor confidence and drive the stock price up in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100